The global “spinal cord stimulation market” is expected to reach USD 4.12 billion by 2027, exhibiting a CAGR of 8.0% during the forecast period. The increasing acceptance of minimally invasive therapies can have a tremendous impact on the global market, states Fortune Business Insights, in a report, titled “Global Spinal Cord Stimulation Market Size, Share & COVID-19 Impact Analysis
The coronavirus incident has caused massive loss and disruption to various industries across the globe. We understand that this health disaster has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling and some are thriving.
We are making endless efforts to uplift businesses in this crucial need of the hour. Our expertise and experience can offer enormous benefits to help regain this global pandemic.
Request a Sample Copy of the Research Report
Increasing Prevalence of Obesity to Favor Growth
The increasing incidence of obesity among the younger population is propelling the need to adopt a healthy lifestyle across the globe.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving.
Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak.
The Report Lists the Key Companies in the Global Spinal Cord Stimulation Market:
- Boston Scientific Corporation (Massachusetts, U.S.)
- Medtronic (Dublin, Ireland)
- Abbott (Illinois, U.S.)
- Nevro Corp (California, U.S.)
- Nuvectra (Texas, U.S.)
- Stimwave LLC (Florida, U.S.)
- Other prominent players
Leave a Reply